Periscope Capital’s Instinct Bio Technical Company Holdings Warrants BIOTW Stock Holding History

Periscope Capital’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.4K	Buy	+160,000	New	+$3.23K	﹤0.01%	502

Other funds holding BIOTW

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $14.9B AUM 3.61% 1-Year Est. Return

Morton Capital Management Calabasas, California $828M AUM 13.29% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Landscape Capital Management Englewood, New Jersey $1.34B AUM 18.69% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Periscope Capital's BIOTW Position: Q3 2026 in Review

Periscope Capital opened a new position in Instinct Bio Technical Company Holdings Warrants (BIOTW) in Q3 2026: 160,000 shares worth $2.4K. The stake represents ﹤0.01% of the portfolio and ranks #502 among its holdings.

8 funds tracked by Wall St. Rank hold BIOTW as of Q3 2026.

Periscope Capital held 160,000 shares of Instinct Bio Technical Company Holdings Warrants worth $2.4K as of Q3 2026.
Instinct Bio Technical Company Holdings Warrants was a new Periscope Capital position in Q3 2026.
Instinct Bio Technical Company Holdings Warrants made up ﹤0.01% of Periscope Capital's portfolio in Q3 2026, its #502 holding.
8 funds tracked by Wall St. Rank held Instinct Bio Technical Company Holdings Warrants as of Q3 2026.

Based on Periscope Capital's 13F filing for Q3 2026, filed 6 Nov 2026.